NCT07044245

Brief Summary

Tooth loss is accompanied by bone loss in all dimensions, so preservation of the bone is mandatory for placement of dental implant, as bone quantity and quality are predictive factors in achieving proper primary stability. Low level bio stimulation has stimulatory effect on bone cells so it can be used in immediate implants to increase bone formation around the implant. the Aim of this study is to evaluate the effect of low-level diode laser Biostimulation on immediate implants in maxillary premolars.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 19, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 29, 2025

Completed
Last Updated

June 29, 2025

Status Verified

June 1, 2025

Enrollment Period

9 months

First QC Date

June 19, 2025

Last Update Submit

June 27, 2025

Conditions

Keywords

immediate implantISQLLLTclinical stability

Outcome Measures

Primary Outcomes (1)

  • Implant Stability Assessment using Radio frequency analysis

    Secondary implant stability analysis was performed 4-months after implant placement. Radio frequency analysis (RFA) was performed using Osstell device (Integration diagnostic Ltd. Company, Sävedalen, Sweden). Primary and secondary implant stability were analyzed and compared. The use of the Osstell and ISQ values were obtained by a blinded operator

    4 month

Secondary Outcomes (1)

  • Radiographic assessment of the management of the crestal bone width and changes in labial bone thickness.

    4 months

Study Arms (2)

Patients with immediate implant placement in maxillary premolars receiving low laser Biostimulation

ACTIVE COMPARATOR

Patients with immediate implant placement in maxillary premolars receiving low laser Biostimulation after placement on two sessions

Procedure: immediate maxillary premolar implant placement with subsequent laser Biostimulation

Patients with immediate implant placement in maxillary premolars receiving sham laser

SHAM COMPARATOR

Patients with immediate implant placement in maxillary premolars receiving sham laser as a control

Procedure: immediate maxillary premolar implant placement with no subsequent laser Biostimulation

Interventions

Sham laser application

Patients with immediate implant placement in maxillary premolars receiving sham laser

low lever biostimulation was performed on two consecutive sessions each of 100 s. First session was carried out immediately on surgery time after implant placement, using a diode laser Photo-biomodulation tip in a continuous wave and non-contact mode

Patients with immediate implant placement in maxillary premolars receiving low laser Biostimulation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with unrestorable maxillary premolars with sufficient bone quantity to receive the dental implant.
  • Age ranging from 25-45.
  • Patients with no local or systemic pathology that can interfere with normal wound healing.
  • Non- smokers.
  • Patients that are properly motivated to complete follow up visits.
  • Patients with adequate oral hygiene or willing to improve their oral hygiene to ensure uncompromised wound healing.

You may not qualify if:

  • Patients with uncontrolled medical condition that can affect surgical outcome or bone and wound healing. (ex: diabetes mellitus)
  • Patients with periapical pathology that may contraindicate immediate implant placement.
  • History of receiving irradiation in head and neck region

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry, Alexandria University

Alexandria, Alexandria Governorate, 21523, Egypt

Location

Study Officials

  • yehia El-Mahallawy, Phd

    Faculty of Dentistry, Alexandria University, Alexandria, Alexandria

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Sequentially numbered, opaque, sealed envelopes (SNOSE) allocation concealment method will be utilized. Each participant included in the study will be given a serial number that will be used in the allocation. These numbers will be written in identical sheets of paper with the group to which each participant is allocated and placed inside opaque envelopes carrying the respective names of participants. A trial independent personnel will be assigned the role of keeping the envelopes and unfolding them only at the time of the operation, so that the participant is allocated to a group which is concealed from the operator Furthermore, outcome assessor was blinded from the group enrollment
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients with immediate implant placement in the of maxillary premolars with low laser Biostimulation
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 19, 2025

First Posted

June 29, 2025

Study Start

November 1, 2023

Primary Completion

August 1, 2024

Study Completion

March 1, 2025

Last Updated

June 29, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

all data will be de-identified to protect the participant data. patients signed an informed consent for the use of their medical records and data for study

Shared Documents
SAP
Access Criteria
to any one who required them after deidentification

Locations